143.60
price up icon0.21%   0.28
 
loading
Schlusskurs vom Vortag:
$143.32
Offen:
$143.51
24-Stunden-Volumen:
1.40M
Relative Volume:
0.99
Marktkapitalisierung:
$21.06B
Einnahmen:
$9.61B
Nettoeinkommen (Verlust:
$1.53B
KGV:
13.73
EPS:
10.46
Netto-Cashflow:
$1.85B
1W Leistung:
+0.02%
1M Leistung:
+3.63%
6M Leistung:
+3.00%
1J Leistung:
-28.04%
1-Tages-Spanne:
Value
$143.02
$147.23
1-Wochen-Bereich:
Value
$139.54
$150.28
52-Wochen-Spanne:
Value
$110.03
$204.18

Biogen Inc Stock (BIIB) Company Profile

Name
Firmenname
Biogen Inc
Name
Telefon
(781) 464-2000
Name
Adresse
225 BINNEY STREET, CAMBRIDGE, MA
Name
Mitarbeiter
7,605
Name
Twitter
@biogen
Name
Nächster Verdiensttermin
2024-10-30
Name
Neueste SEC-Einreichungen
Name
BIIB's Discussions on Twitter

Vergleichen Sie BIIB mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Drug Manufacturers - General icon
BIIB
Biogen Inc
143.62 21.01B 9.61B 1.53B 1.85B 10.46
Drug Manufacturers - General icon
LLY
Lilly Eli Co
764.57 670.72B 53.26B 13.80B -50.20M 15.30
Drug Manufacturers - General icon
JNJ
Johnson Johnson
176.57 427.24B 90.62B 22.66B 18.18B 9.35
Drug Manufacturers - General icon
ABBV
Abbvie Inc
216.74 384.42B 58.33B 3.73B 18.24B 2.10
Drug Manufacturers - General icon
NVS
Novartis Ag Adr
123.07 238.71B 53.40B 13.68B 16.89B 6.9231
Drug Manufacturers - General icon
MRK
Merck Co Inc
81.17 202.37B 63.43B 16.42B 14.72B 6.49

Biogen Inc Stock (BIIB) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-07-21 Fortgesetzt Truist Hold
2025-04-28 Herabstufung HSBC Securities Buy → Hold
2025-04-04 Herabstufung Argus Buy → Hold
2025-02-11 Eingeleitet Bernstein Mkt Perform
2025-01-02 Herabstufung Piper Sandler Overweight → Neutral
2024-12-20 Herabstufung BMO Capital Markets Outperform → Market Perform
2024-12-16 Herabstufung Stifel Buy → Hold
2024-12-10 Fortgesetzt BofA Securities Neutral
2024-12-09 Herabstufung Jefferies Buy → Hold
2024-11-18 Herabstufung Needham Buy → Hold
2024-11-15 Eingeleitet Wolfe Research Peer Perform
2024-11-14 Eingeleitet Citigroup Neutral
2024-10-31 Herabstufung Morgan Stanley Overweight → Equal-Weight
2024-10-10 Fortgesetzt Raymond James Mkt Perform
2024-02-14 Bestätigt Needham Buy
2024-02-14 Herabstufung Wells Fargo Overweight → Equal Weight
2024-01-24 Herabstufung UBS Buy → Neutral
2023-12-20 Fortgesetzt Cantor Fitzgerald Overweight
2023-12-07 Hochstufung Raymond James Mkt Perform → Outperform
2023-09-06 Eingeleitet HSBC Securities Buy
2023-07-27 Eingeleitet Scotiabank Sector Outperform
2023-07-24 Bestätigt UBS Buy
2023-05-01 Hochstufung Guggenheim Neutral → Buy
2023-04-17 Hochstufung Piper Sandler Neutral → Overweight
2022-10-26 Hochstufung Goldman Neutral → Buy
2022-10-13 Hochstufung Stifel Hold → Buy
2022-10-07 Hochstufung Argus Hold → Buy
2022-09-28 Hochstufung BMO Capital Markets Market Perform → Outperform
2022-09-28 Hochstufung Mizuho Neutral → Buy
2022-09-28 Hochstufung Robert W. Baird Neutral → Outperform
2022-04-18 Hochstufung Wells Fargo Equal Weight → Overweight
2022-03-08 Herabstufung Stifel Buy → Hold
2022-03-03 Hochstufung RBC Capital Mkts Sector Perform → Outperform
2022-02-04 Herabstufung BMO Capital Markets Outperform → Market Perform
2022-02-04 Bestätigt Barclays Equal Weight
2022-02-04 Bestätigt BofA Securities Neutral
2022-02-04 Bestätigt Cowen Outperform
2022-02-04 Bestätigt Morgan Stanley Overweight
2022-02-04 Bestätigt Needham Buy
2022-02-04 Bestätigt Oppenheimer Outperform
2022-02-04 Bestätigt RBC Capital Mkts Sector Perform
2022-02-04 Bestätigt Robert W. Baird Neutral
2022-02-04 Bestätigt Wedbush Neutral
2022-02-04 Bestätigt Wells Fargo Equal Weight
2022-02-04 Bestätigt Wolfe Research Peer Perform
2022-01-13 Herabstufung Guggenheim Buy → Neutral
2022-01-12 Herabstufung Piper Sandler Overweight → Neutral
2021-12-10 Fortgesetzt Raymond James Mkt Perform
2021-12-09 Fortgesetzt Wells Fargo Equal Weight
2021-12-06 Eingeleitet Goldman Neutral
2021-11-19 Eingeleitet BMO Capital Markets Outperform
2021-09-23 Eingeleitet Needham Buy
2021-06-18 Hochstufung Piper Sandler Neutral → Overweight
2021-06-14 Bestätigt Truist Buy
2021-06-11 Hochstufung Bernstein Mkt Perform → Outperform
2021-06-10 Hochstufung UBS Neutral → Buy
2021-06-08 Hochstufung Atlantic Equities Underweight → Neutral
2021-06-08 Bestätigt Barclays Equal Weight
2021-06-08 Hochstufung Citigroup Sell → Neutral
2021-06-08 Bestätigt H.C. Wainwright Buy
2021-06-08 Bestätigt Jefferies Buy
2021-06-08 Bestätigt Morgan Stanley Overweight
2021-06-08 Bestätigt RBC Capital Mkts Sector Perform
2021-06-08 Hochstufung Robert W. Baird Underperform → Neutral
2021-06-08 Bestätigt Stifel Buy
2021-06-08 Hochstufung William Blair Mkt Perform → Outperform
2021-06-07 Hochstufung BofA Securities Underperform → Neutral
2021-06-07 Hochstufung Cowen Market Perform → Outperform
2021-06-07 Hochstufung Raymond James Underperform → Mkt Perform
2021-02-05 Herabstufung DZ Bank Buy → Hold
2021-01-29 Hochstufung Stifel Hold → Buy
2020-11-10 Hochstufung DZ Bank Hold → Buy
2020-11-09 Herabstufung Atlantic Equities Neutral → Underweight
2020-11-09 Herabstufung BofA Securities Neutral → Underperform
2020-11-09 Herabstufung Cowen Outperform → Market Perform
2020-11-09 Bestätigt H.C. Wainwright Buy
2020-11-04 Hochstufung BofA Securities Underperform → Neutral
2020-11-04 Hochstufung Jefferies Hold → Buy
2020-11-04 Hochstufung Wells Fargo Equal Weight → Overweight
2020-10-28 Eingeleitet UBS Neutral
2020-07-27 Hochstufung Morgan Stanley Underweight → Overweight
2020-06-22 Herabstufung Barclays Overweight → Equal Weight
2020-06-22 Bestätigt RBC Capital Mkts Sector Perform
2020-06-09 Herabstufung Bernstein Outperform → Mkt Perform
2020-04-23 Herabstufung Citigroup Neutral → Sell
2020-04-23 Herabstufung Raymond James Mkt Perform → Underperform
2020-03-31 Eingeleitet Wolfe Research Peer Perform
2020-02-27 Eingeleitet Barclays Overweight
2020-01-27 Hochstufung Canaccord Genuity Hold → Buy
2019-12-13 Hochstufung Credit Suisse Underperform → Neutral
2019-12-02 Herabstufung Robert W. Baird Neutral → Underperform
Alle ansehen

Biogen Inc Aktie (BIIB) Neueste Nachrichten

pulisher
11:25 AM

Biogen's new building kicks off Kendall Common project - The Business Journals

11:25 AM
pulisher
07:05 AM

Does FDA Progress Reinforce C4 Therapeutics' (CCCC) Platform Validation Story in Autoimmune Disease? - uk.finance.yahoo.com

07:05 AM
pulisher
06:58 AM

Investors Research Corp Invests $232,000 in Biogen Inc. $BIIB - MarketBeat

06:58 AM
pulisher
05:06 AM

Fred Alger Management LLC Acquires Shares of 12,159 Biogen Inc. $BIIB - MarketBeat

05:06 AM
pulisher
04:34 AM

AG2R LA Mondiale Gestion D Actifs Makes New $992,000 Investment in Biogen Inc. $BIIB - MarketBeat

04:34 AM
pulisher
04:08 AM

2,150 Shares in Biogen Inc. $BIIB Purchased by MBB Public Markets I LLC - MarketBeat

04:08 AM
pulisher
03:41 AM

Strs Ohio Purchases Shares of 34,000 Biogen Inc. $BIIB - MarketBeat

03:41 AM
pulisher
03:35 AM

Biogen Inc. $BIIB Shares Sold by UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC - MarketBeat

03:35 AM
pulisher
02:09 AM

United Services Automobile Association Invests $499,000 in Biogen Inc. $BIIB - MarketBeat

02:09 AM
pulisher
02:09 AM

Biogen Inc. $BIIB Shares Bought by Woodline Partners LP - MarketBeat

02:09 AM
pulisher
Sep 15, 2025

Portfolio Update: How do insiders feel about Biogen IncJuly 2025 Volume & Technical Pattern Based Signals - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

Why C4 Therapeutics Stock Crushed the Market on Monday - The Motley Fool

Sep 15, 2025
pulisher
Sep 15, 2025

EPS Watch: Is Biogen Inc. exposed to political riskEarnings Beat & AI Powered Market Entry Ideas - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

Death Cross: Will Biogen Inc stock go up in YEAREarnings Overview Summary & Weekly Consistent Profit Watchlists - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

Aug Sentiment: Is Biogen Inc being accumulated by smart moneyGold Moves & Growth Focused Entry Point Reports - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

H.C. Wainwright Affirms Biogen Inc. (BIIB) Buy Rating on Lupus Franchise Prospects - Yahoo Finance

Sep 15, 2025
pulisher
Sep 15, 2025

Earnings Update: Is Biogen Inc. showing insider buying2025 Bull vs Bear & Real-Time Buy Zone Alerts - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

2,551 Shares in Biogen Inc. $BIIB Bought by Teza Capital Management LLC - MarketBeat

Sep 15, 2025
pulisher
Sep 15, 2025

Jacobi Capital Management LLC Acquires 2,064 Shares of Biogen Inc. $BIIB - MarketBeat

Sep 15, 2025
pulisher
Sep 15, 2025

Biogen Inc. $BIIB Shares Acquired by Swedbank AB - MarketBeat

Sep 15, 2025
pulisher
Sep 14, 2025

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Raises Stock Holdings in Biogen Inc. $BIIB - MarketBeat

Sep 14, 2025
pulisher
Sep 14, 2025

Jacobs Levy Equity Management Inc. Takes Position in Biogen Inc. $BIIB - MarketBeat

Sep 14, 2025
pulisher
Sep 13, 2025

Alliancebernstein L.P. Raises Stake in Biogen Inc. $BIIB - MarketBeat

Sep 13, 2025

Finanzdaten der Biogen Inc-Aktie (BIIB)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Biogen Inc-Aktie (BIIB) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Singhal Priya
Head of Development
Sep 02 '25
Sale
133.55
517
69,045
5,772
drug_manufacturers_general SNY
$47.02
price up icon 0.84%
drug_manufacturers_general PFE
$23.98
price up icon 0.10%
$111.16
price down icon 1.32%
$272.81
price down icon 0.67%
drug_manufacturers_general NVO
$57.32
price up icon 3.03%
drug_manufacturers_general MRK
$81.13
price up icon 0.18%
Kapitalisierung:     |  Volumen (24h):